Xinting Sang

19PUBLICATIONS
19CO-AUTHORS
Haematological tumoursPredictive and prognostic markersChemotherapyMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 18, 2026
Real-World Study of Post-Recurrence Treatment Strategies for Microvascular Invasion-Positive Hepatocellular Carcinoma After Curative Resection.

|Oct 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study.

Xiaokun Chen, Jiali Xing, Baoluhe Zhang

|Mar 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.

Xiaokun Chen, Xiangan Wu, Wei Peng

|Oct 10, 2023
Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma.

Bao Jin, Yuxin Wang, Baoluhe Zhang

|Jul 18, 2023
Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery.

Lejia Sun, Xindi Ke, Ai Guan

|May 29, 2023
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.

Chengpei Zhu, Hu Li, Xiaobo Yang

Pageof 4

Frequent Collaborators

8 joint publications

Yilei Mao

6 joint publications

Shunda Du

4 joint publications

Haitao Zhao

3 joint publications

Xiao Liu